Regeneron Pharma (REGN) PT Raised to $842 at H.C. Wainwright, Following Clinical Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Regeneron (NASDAQ: REGN) | Delayed: 961.43 -11.93 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $973.36 | 52 Week High | $592.36 | |||
| Open | $989.90 | 52 Week Low | $325.35 | |||
| Day High | $991.73 | P/E | 252.34 | |||
| Day Low | $941.29 | EPS | $3.81 | |||
| Volume | 460,254 | |||||
